The independent source for health policy research, polling, and news.
About one in eight adults say that they are currently taking a GLP-1 drug either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern. Few adults think it is likely their prescription costs will go down as a result of recently announced Trump administration policies.
As the Trump administration announces a new partnership with private companies and the Centers for Medicare and Medicaid Services to expand access to digital health tools like apps, this KFF Health Tracking poll finds that most adults have used these tools to manage their care. However, even amid widespread use of health care-related apps, majorities of adults are concerned about the privacy of their information, regardless of whether an app is managed by the government, a private technology company, or a health insurance company.
Timely insights and analysis from KFF staff
Based on interviews with more than 2,700 parents, including more than 1,000 parents with children under age 6 who have had to make decisions about vaccines in the post-COVID era, this survey explores parents’ experiences with and views about vaccines for their children.
Our signature survey project provides up-to-date data on the public’s health care views, knowledge, and experiences.
Search all KFF polls since 1992 by keyword and date to find full question wording and results.
The Health Information and Trust Tracking Poll is part of KFF’s Health Information and Trust Initiative, which tracks health misinformation and analyzes its impact on the public.
This chapter of our digital “textbook” explores why surveys are essential for understanding health policy issues.
Choose which emails are best for you.
Sign up here
